Fundz

Countable Labs raises $26 million to accelerate clinical product development and expand commercialization of Countable PCR, led by ARCH Venture Partners.

PRIVATEMay 28, 2026

Amount Raised

$26 Million

Round Type

Funding Round

Palo AltoBiotechnologyHealth CareGeneticsLife ScienceHealth Diagnostics

Investors

F Prime CapitalPrimer VenturesARCH Venture Partners

Description

Countable Labs has closed an oversubscribed $26 million financing round to enhance its Countable PCR technology. The funding, led by ARCH Venture Partners, will support the company's expansion into cell and gene therapy, oncology, and molecular diagnostics. Additional participation included F-Prime Capital and Primer Ventures. The investment will help bring innovative solutions to laboratories needing sensitive genomics measurement.

Who else raised in Genetics and Life Science around the same time

Companies in the same sectors as Countable Labs that raised within 45 days of this round, from Fundz verified event records.

  • Grail raised $110M (Post-IPO Equity) on June 25, 2026.
  • 4baseCare raised $4M (Series B) on June 11, 2026.
  • Element Biosciences raised $175M (Series E) on June 9, 2026.
  • Telepatía AI raised $33M (Series A) on July 9, 2026.
  • Respiro Diagnostics raised $1.3M (Pre-Seed) on July 8, 2026.
  • Pictor raised $7.5M (Funding Round) on July 1, 2026.

Who to call at Countable Labs, and when

A new round usually means Countable Labs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Countable Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Countable Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Countable Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Countable Labs

Location

Palo Alto, California, United States

About

Countable Labs is the developer of Countable PCR, a breakthrough single-molecule PCR technology that redefines how science measures biology. The technology offers superior sensitivity and precision, making it ideal for applications in cell and gene therapy, minimal residual disease testing, and other molecular diagnostics. Countable Labs aims to democratize access to genomic tools and is poised for long-term growth in the life sciences sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Countable Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKurt D., Head of Commercial, North America hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Countable Labs's next move

See what Strategic adds

Countable Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.